| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/26/2002 | CN1355310A Polypeptide-human protein phosphatase 2A alpha subunit 22.66 and polynucleotide for coding it |
| 06/26/2002 | CN1355309A Polypeptide-human protein phosphatase 1 regulatory factor subunit 10-9.79 and polynucleotide for coding it |
| 06/26/2002 | CN1355308A Polypeptide-human RNA uncoiling enzyme 12.54 and polynucleotide for coding it |
| 06/26/2002 | CN1355307A Polypeptide-human uridylic acid kinase 9.57 and polynucleotide for coding it |
| 06/26/2002 | CN1355306A Polypeptide-human protein kinase Nek2-11.11 and polynucleotide for coding it |
| 06/26/2002 | CN1355305A Polypeptide-Ser/Thr protein kinase 9.79 and polynucleotide for coding it |
| 06/26/2002 | CN1355304A Polypeptide-human VD hydroxylase 11.88 and polynucleotide for coding it |
| 06/26/2002 | CN1355303A Polypeptide-human lysyloxidase 54.45 and polynucleotide for coding it |
| 06/26/2002 | CN1355302A Polypeptide-short-chain dehydrogenase/reductase 10.89 and polynucleotide for coding it |
| 06/26/2002 | CN1355301A Polypeptide-human pterin Mo oxido-reductase 14.63 and polynucleotide for coding it |
| 06/26/2002 | CN1355300A Polypeptide-human tyrosinase 46.64 and polynucleotide for coding it |
| 06/26/2002 | CN1355299A Polypeptide-human uracil diphosphate glycopyrophosphorylase 100.47 and polynucleotide for coding it |
| 06/26/2002 | CN1355298A Polypeptide-40KDa subunit 9.35 of RNA polymerase I and polynucleotide for coding it |
| 06/26/2002 | CN1355297A Polypeptide-human ubiquitin activating enzyme E1-13.53 and polynucleotide for coding it |
| 06/26/2002 | CN1355296A Polypeptide-human leucoma pro protein conveyzyme 10.89 and polynucleotide for coding it |
| 06/26/2002 | CN1086739C Single tube synchronous three-step PCR checkout method for chlamydia trachomatis, deurea elementary body and Neisseria gonorrhoeae and used primer |
| 06/25/2002 | US6410775 APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
| 06/25/2002 | US6410725 Nucleotide sequence extraction; obtain nuclelotide sequence sample, incubate with extraction solution, isolate supernatant containing extracted nucleotide sequences |
| 06/25/2002 | US6410724 Nucleotide sequences for use in the diagnosis of liver cancer |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410704 Nucleotide sequences coding enzymatic polypeptide for use in treatment of viral disease |
| 06/25/2002 | US6410702 Oligonucleotide; for use in the human therapeutics and diagnostics |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410689 Caspase recruitment domain polypeptides |
| 06/25/2002 | US6410687 Polypeptide; for use as antiproliferative agents |
| 06/25/2002 | US6410675 Functionalized silicon compounds and methods for their synthesis and use |
| 06/25/2002 | US6410668 Coated microchannel; electrophoresis |
| 06/25/2002 | US6410516 Nuclear factors associated with transcriptional regulation |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410336 Method reagent and kit for the detection of fecal occult blood |
| 06/25/2002 | US6410323 Nucleotide sequences for use in the treatment of cell proliferation defects |
| 06/25/2002 | US6410321 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments |
| 06/25/2002 | US6410315 Genes encoding polypeptides containing signal sequences |
| 06/25/2002 | US6410312 huBUB3 gene involved in human cancers |
| 06/25/2002 | US6410307 Apparatus for monitoring cell activities; for use in monitoring activity of antitumor agents |
| 06/25/2002 | US6410296 Herpes virus proteinase and method of assaying |
| 06/25/2002 | US6410290 Catalases |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410278 Process for synthesizing nucleic acid |
| 06/25/2002 | US6410277 DNA polymersases with enhanced length of primer extension |
| 06/25/2002 | US6410276 Selective amplification of target polynucleotide sequences |
| 06/25/2002 | US6410275 Disposable test devices for performing nucleic acid amplification reactions |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410261 CIITA-interacting proteins and methods of use therefor |
| 06/25/2002 | US6410255 Optical probes and assays |
| 06/25/2002 | US6410254 Compositions and assays utilizing ADP or phosphate for detecting protein modulators |
| 06/25/2002 | US6410253 Cholesterol oxidase |
| 06/25/2002 | US6410251 Redox system |
| 06/25/2002 | US6410249 Odorant receptors |
| 06/25/2002 | US6410245 Complexing; fusion proteins; quantitative analysis |
| 06/25/2002 | US6410243 Crosslinking; separation |
| 06/25/2002 | US6410242 Transparent capsule; precipitation |
| 06/25/2002 | US6410241 Methods of screening open reading frames to determine whether they encode polypeptides with an ability to generate an immune response |
| 06/25/2002 | US6410240 Complexing |
| 06/25/2002 | US6410239 Identification and comparison of protein—protein interactions that occur in populations and identification of inhibitors of these interactors |
| 06/25/2002 | US6410237 DNA encoding canine von Willebrand factor and methods of use |
| 06/25/2002 | US6410236 In situ cultured mammalian cardiac mycote comprising nucleic acid |
| 06/25/2002 | US6410235 Amplification; complexing; separation |
| 06/25/2002 | US6410233 Isolation and identification of control sequences and genes modulated by transcription factors |
| 06/25/2002 | US6410231 Target polynucleotides are immobilized by hybridization |
| 06/25/2002 | US6410229 Expression monitoring by hybridization to high density nucleic acid arrays |
| 06/25/2002 | US6410228 Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regions |
| 06/25/2002 | US6410227 DNA markers for litter size |
| 06/25/2002 | US6410226 Quantitative analysis; calibration |
| 06/25/2002 | US6410223 Detection target dna; culturing, amplification |
| 06/25/2002 | US6410219 Dectionn of pathogen deaction of pathogen by complexing |
| 06/25/2002 | US6410029 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/25/2002 | US6410015 Selecting from bone marrow-derived cells population responsive to transforming growth factor beta-1, using as vehicles for transferring genes encoding therapeutic protein to mammal |
| 06/25/2002 | US6410013 Viral vectors for use in monitoring HIV drug resistance |
| 06/25/2002 | US6409664 Nomograms to aid in the treatment of prostatic cancer |
| 06/25/2002 | US6408878 Microfabricated elastomeric valve and pump systems |
| 06/25/2002 | CA2282042C Solid phase enzyme kinetics screening in microcolonies |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2194393C Mammalian telomerase |
| 06/25/2002 | CA2161778C Detection of prostate-specific antigen in breast tumors |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/25/2002 | CA2092917C Hair analysis method |
| 06/25/2002 | CA2085881C Dna encoding mammalian phosphodiesterases |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/22/2002 | CA2365791A1 Novel bioluminescent assays and bacterial strains useful therein |
| 06/22/2002 | CA2365673A1 Methods, compositions and kits relating to cardiovascular disease |
| 06/22/2002 | CA2365669A1 Methods and reagents for detecting increased risk of developing an inflammatory disorder |
| 06/20/2002 | WO2002048714A1 Method of cancer estimation by alp isozymes |
| 06/20/2002 | WO2002048703A1 Analytical element, and measuring instrument and substrate determining method using the same |
| 06/20/2002 | WO2002048676A2 Multiple array system for integrating bioarrays |
| 06/20/2002 | WO2002048674A2 Methods, devices, arrays and kits for detecting and analyzing biomolecules |
| 06/20/2002 | WO2002048405A2 Non-invasive method for detecting target rna |
| 06/20/2002 | WO2002048404A2 Method and kit for enhancing the association rates of polynucleotides |
| 06/20/2002 | WO2002048403A2 Multiplexed protein expression and activity assay |
| 06/20/2002 | WO2002048402A2 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
| 06/20/2002 | WO2002048401A2 Nested oligonucleotides containing hairpin for nucleic acid amplification |
| 06/20/2002 | WO2002048400A1 Method of estimating risk of the expression of side effect caused by the administration of compound metabolized, either per se or as its metabolic intermediate, by ugt1a1 enzyme |
| 06/20/2002 | WO2002048399A2 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna |
| 06/20/2002 | WO2002048398A2 In situ hybridization system for specifically detecting microorganisms |
| 06/20/2002 | WO2002048396A2 Sensor for detecting macromolecular biopolymers |
| 06/20/2002 | WO2002048395A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 06/20/2002 | WO2002048393A2 Light-activated in vitro assay process for luciferase bioluminescence |